The next step toward moving to dissemination involved evaluating whether CBT4CBT could be delivered safely as a stand-alone intervention rather than an adjunct to treatment. Therefore, our third trial involved an adaptation of CBT4CBT for individuals with primary alcohol use disorders in which 68 individuals were randomly assigned to one of three conditions: standard outpatient alcohol treatment in a community based setting (predominantly weekly group therapy, TAU), TAU plus CBT4CBT, or CBT4CBT delivered with only brief clinical monitoring (about 10 minutes each week). The clinical monitoring sessions were offered because this was moderately severe (baseline AUDIT mean was 19), treatment-seeking sample who met criteria for DSM-IV-R alcohol dependence) and the weekly brief check-ins provided an opportunity to closely monitor each participant’s clinical status and determine if this level of care was sufficient. Results indicated significantly higher rates of treatment completion in either condition offering CBT4CBT compared to TAU (CBT4CBT+TAU=65%; CBT4CBT alone, 63%, TAU 26%). Percentages of participants with no heavy drinking days in the last 4 weeks of treatment were 9% for TAU, 37% for TAU+CBT4CBT, and 33% for CBT4CBT
